Inhibiting menin to treat myeloproliferative neoplasms shows preclinical promise
July 09, 2026
July 09, 2026
MEMPHIS, Tennessee, July 9 [Category: BizHospital] -- St. Jude Children's Research Hospital issued the following news release:
* * *
Inhibiting menin to treat myeloproliferative neoplasms shows preclinical promise
*
Inhibiting menin, a protein that supports leukemia growth and is already targeted to treat some forms of leukemia, also holds promise for treating myeloproliferative neoplasms. A new study from scientists at St. Jude Children . . .
* * *
Inhibiting menin to treat myeloproliferative neoplasms shows preclinical promise
*
Inhibiting menin, a protein that supports leukemia growth and is already targeted to treat some forms of leukemia, also holds promise for treating myeloproliferative neoplasms. A new study from scientists at St. Jude Children . . .
